Myofiber wasting in muscular dystrophy has largely been ascribed to necrotic cell death, despite reports identifying apoptotic markers in dystrophic muscle. Here we set out to identify the contribution of canonical apoptotic pathways to skeletal muscle degeneration in muscular dystrophy by genetically deleting a known inhibitor of apoptosis, apoptosis repressor with a card domain (Arc), in dystrophic mouse models. Nol3 (Arc protein) genetic deletion in the dystrophic Sgcd or Lama2 null backgrounds showed exacerbated skeletal muscle pathology with decreased muscle performance compared with single null dystrophic littermate controls. The enhanced severity of the dystrophic phenotype associated with Nol3 deletion was caspase independent but dependent on the mitochondria permeability transition pore (MPTP), as the inhibitor Debio-025 partially rescued skeletal muscle pathology in Nol3-/-Sgcd-/- double targeted mice. Mechanistically, Nol3-/-Sgcd-/- mice showed elevated total and mitochondrial Bax protein levels, as well as greater mitochondrial swelling, suggesting that Arc normally restrains the cell death effects of Bax in skeletal muscle. Indeed, knockdown of Arc in mouse embryonic fibroblasts caused an increased sensitivity to cell death that was fully blocked in Bax Bak1 (genes encoding Bax and Bak) double null fibroblasts. Thus Arc deficiency in dystrophic muscle exacerbates disease pathogenesis due to a Bax-mediated sensitization of mitochondria-dependent death mechanisms.
References
[1]
Millay DP, Goonasekera SA, Sargent MA, Maillet M, Aronow BJ et al. (2009) Calcium influx is sufficient to induce muscular dystrophy through a TRPC-dependent mechanism. Proc Natl Acad Sci U S A 106: 19023-19028. doi:10.1073/pnas.0906591106. PubMed: 19864620.
Yasuda S, Townsend D, Michele DE, Favre EG, Day SM et al. (2005) Dystrophic heart failure blocked by membrane sealant poloxamer. Nature 436: 1025-1029. doi:10.1038/nature03844. PubMed: 16025101.
[4]
Goldstein JA, McNally EM (2010) Mechanisms of muscle weakness in muscular dystrophy. J Gen Physiol 136: 29-34. doi:10.1085/jgp.201010436. PubMed: 20584890.
[5]
Honda A, Abe S, Hiroki E, Honda H, Iwanuma O, et al. (2007) Activation of caspase 3, 9, 12, and Bax in masseter muscle of mdx mice during necrosis. J Muscle Res Cell Motil 28: 243-247.
[6]
Matsuda R, Nishikawa A, Tanaka H (1995) Visualization of dystrophic muscle fibers in mdx mouse by vital staining with Evans blue: evidence of apoptosis in dystrophin-deficient muscle. J Biochem 118: 959-964. doi:10.1093/jb/118.5.959. PubMed: 8749313.
[7]
Smith J, Fowkes G, Schofield PN (1995) Programmed cell death in dystrophic (mdx) muscle is inhibited by IGF-II. Cell Death Differ 2: 243-251. PubMed: 17180029.
[8]
Tidball JG, Albrecht DE, Lokensgard BE, Spencer MJ (1995) Apoptosis precedes necrosis of dystrophin-deficient muscle. J Cell Sci 108 ( 6): 2197-2204. PubMed: 7673339.
[9]
Bray GM, Banker BQ (1970) An ultrastructural study of degeneration and necrosis of muscle in the dystrophic mouse. Acta Neuropathol 15: 34-44. doi:10.1007/BF00690687. PubMed: 4907318.
[10]
Caulfield JB (1966) Electron microscopic observations on the dystrophic hamster muscle. Ann N Y Acad Sci 138: 151-159. PubMed: 5230206.
[11]
Millay DP, Sargent MA, Osinska H, Baines CP, Barton ER et al. (2008) Genetic and pharmacologic inhibition of mitochondrial-dependent necrosis attenuates muscular dystrophy. Nat Med 14: 442-447. doi:10.1038/nm1736. PubMed: 18345011.
[12]
Woo M, Tanabe Y, Ishii H, Nonaka I, Yokoyama M et al. (1987) Muscle fiber growth and necrosis in dystrophic muscles: a comparative study between dy and mdx mice. J Neurol Sci 82: 111-122. doi:10.1016/0022-510X(87)90011-6. PubMed: 3440862.
[13]
Hack AA, Ly CT, Jiang F, Clendenin CJ, Sigrist KS et al. (1998) Gamma-sarcoglycan deficiency leads to muscle membrane defects and apoptosis independent of dystrophin. J Cell Biol 142: 1279-1287. doi:10.1083/jcb.142.5.1279. PubMed: 9732288.
[14]
Sandri M, El Meslemani AH, Sandri C, Schjerling P, Vissing K et al. (2001) Caspase 3 expression correlates with skeletal muscle apoptosis in Duchenne and facioscapulo human muscular dystrophy. A potential target for pharmacological treatment? J Neuropathol Exp Neurol 60: 302-312. PubMed: 11245214.
[15]
Charriaut-Marlangue C, Ben-Ari Y (1995) A cautionary note on the use of the TUNEL stain to determine apoptosis. Neuroreport 7: 61-64. doi:10.1097/00001756-199512290-00014. PubMed: 8742417.
[16]
Angelin A, Tiepolo T, Sabatelli P, Grumati P, Bergamin N et al. (2007) Mitochondrial dysfunction in the pathogenesis of Ullrich congenital muscular dystrophy and prospective therapy with cyclosporins. Proc Natl Acad Sci U S A 104: 991-996. doi:10.1073/pnas.0610270104. PubMed: 17215366.
[17]
Wissing ER, Millay DP, Vuagniaux G, Molkentin JD (2010) Debio-025 is more effective than prednisone in reducing muscular pathology in mdx mice. Neuromuscul Disord 20: 753-760. doi:10.1016/j.nmd.2010.06.016. PubMed: 20637615.
[18]
Abmayr S, Crawford RW, Chamberlain JS (2004) Characterization of ARC, apoptosis repressor interacting with CARD, in normal and dystrophin-deficient skeletal muscle. Hum Mol Genet 13: 213-221. PubMed: 14645204.
[19]
Koseki T, Inohara N, Chen S, Nú？ez G (1998) ARC, an inhibitor of apoptosis expressed in skeletal muscle and heart that interacts selectively with caspases. Proc Natl Acad Sci U S A 95: 5156-5160. doi:10.1073/pnas.95.9.5156. PubMed: 9560245.
[20]
Gustafsson AB, Tsai JG, Logue SE, Crow MT, Gottlieb RA (2004) Apoptosis repressor with caspase recruitment domain protects against cell death by interfering with Bax activation. J Biol Chem 279: 21233-21238. doi:10.1074/jbc.M400695200. PubMed: 15004034.
[21]
Nam YJ, Mani K, Ashton AW, Peng CF, Krishnamurthy B et al. (2004) Inhibition of both the extrinsic and intrinsic death pathways through nonhomotypic death-fold interactions. Mol Cell 15: 901-912. doi:10.1016/j.molcel.2004.08.020. PubMed: 15383280.
[22]
Whelan RS, Konstantinidis K, Wei AC, Chen Y, Reyna DE et al. (2012) Bax regulates primary necrosis through mitochondrial dynamics. Proc Natl Acad Sci U S A 109: 6566-6571. doi:10.1073/pnas.1201608109. PubMed: 22493254.
[23]
Karch J, Kwong JQ, Burr AR, Sargent MA, Elrod JW et al. (2013) Bax and Bak function as the outer membrane component of the mitochondrial permeability pore in regulating necrotic cell death in mice. Elife 2: e00772. PubMed: 23991283.
[24]
Donath S, Li P, Willenbockel C, Al-Saadi N, Gross V et al. (2006) Apoptosis repressor with caspase recruitment domain is required for cardioprotection in response to biomechanical and ischemic stress. Circulation 113: 1203-1212. doi:10.1161/CIRCULATIONAHA.105.576785. PubMed: 16505176.
[25]
Zaiman AL, Damico R, Thoms-Chesley A, Files DC, Kesari P et al. (2011) A critical role for the protein apoptosis repressor with caspase recruitment domain in hypoxia-induced pulmonary hypertension. Circulation 124: 2533-2542. doi:10.1161/CIRCULATIONAHA.111.034512. PubMed: 22082675.
[26]
Ekhterae D, Lin Z, Lundberg MS, Crow MT, Brosius FC 3rd et al. (1999) ARC inhibits cytochrome c release from mitochondria and protects against hypoxia-induced apoptosis in heart-derived H9c2 cells. Circ Res 85: e70-e77. doi:10.1161/01.RES.85.12.e70. PubMed: 10590251.
[27]
Hack AA, Lam MY, Cordier L, Shoturma DI, Ly CT et al. (2000) Differential requirement for individual sarcoglycans and dystrophin in the assembly and function of the dystrophin-glycoprotein complex. J Cell Sci 113 ( 14): 2535-2544. PubMed: 10862711.
[28]
Medina-Ramirez CM, Goswami S, Smirnova T, Bamira D, Benson B et al. (2011) Apoptosis inhibitor ARC promotes breast tumorigenesis, metastasis, and chemoresistance. Cancer Res 71: 7705-7715. doi:10.1158/0008-5472.CAN-11-2192. PubMed: 22037876.
[29]
Kuang W, Xu H, Vachon PH, Engvall E (1998) Disruption of the lama2 gene in embryonic stem cells: laminin alpha 2 is necessary for sustenance of mature muscle cells. Exp Cell Res 241: 117-125. doi:10.1006/excr.1998.4025. PubMed: 9633519.
[30]
Goonasekera SA, Lam CK, Millay DP, Sargent MA, Hajjar RJ et al. (2011) Mitigation of muscular dystrophy in mice by SERCA overexpression in skeletal muscle. J Clin Invest 121: 1044-1052. doi:10.1172/JCI43844. PubMed: 21285509.
[31]
Watchko JF, O'Day TL, Hoffman EP (2002) Functional characteristics of dystrophic skeletal muscle: insights from animal models. J Appl Physiol (1985) 93: 407-417. PubMed: 12133845.
[32]
Girgenrath M, Dominov JA, Kostek CA, Miller JB (2004) Inhibition of apoptosis improves outcome in a model of congenital muscular dystrophy. J Clin Invest 114: 1635-1639. doi:10.1172/JCI200422928. PubMed: 15578095.
[33]
Karbowski M, Norris KL, Cleland MM, Jeong SY, Youle RJ (2006) Role of Bax and Bak in mitochondrial morphogenesis. Nature 443: 658-662. doi:10.1038/nature05111. PubMed: 17035996.
[34]
Tait SW, Green DR (2010) Mitochondria and cell death: outer membrane permeabilization and beyond. Nat Rev Mol Cell Biol 11: 621-632. doi:10.1038/nrm2952. PubMed: 20683470.
[35]
Foo RS, Chan LK, Kitsis RN, Bennett MR (2007) Ubiquitination and degradation of the anti-apoptotic protein ARC by MDM2. J Biol Chem 282: 5529-5535. PubMed: 17142834.
[36]
Nam YJ, Mani K, Wu L, Peng CF, Calvert JW et al. (2007) The apoptosis inhibitor ARC undergoes ubiquitin-proteasomal-mediated degradation in response to death stimuli: identification of a degradation-resistant mutant. J Biol Chem 282: 5522-5528. PubMed: 17142452.
[37]
Neuss M, Monticone R, Lundberg MS, Chesley AT, Fleck E et al. (2001) The apoptotic regulatory protein ARC (apoptosis repressor with caspase recruitment domain) prevents oxidant stress-mediated cell death by preserving mitochondrial function. J Biol Chem 276: 33915-33922. doi:10.1074/jbc.M104080200. PubMed: 11438535.
[38]
Chatterjee S, Bish LT, Jayasankar V, Stewart AS, Woo YJ et al. (2003) Blocking the development of postischemic cardiomyopathy with viral gene transfer of the apoptosis repressor with caspase recruitment domain. J Thorac Cardiovasc Surg 125: 1461-1469. doi:10.1016/S0022-5223(02)73229-7. PubMed: 12830068.
[39]
Anversa P, Cheng W, Liu Y, Leri A, Redaelli G et al. (1998) Apoptosis and myocardial infarction. Basic Res Cardiol 93 Suppl 3: 8-12. doi:10.1007/s003950050195. PubMed: 9879436.
[40]
Baines CP, Kaiser RA, Purcell NH, Blair NS, Osinska H et al. (2005) Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death. Nature 434: 658-662. doi:10.1038/nature03434. PubMed: 15800627.
Kajstura J, Cheng W, Reiss K, Clark WA, Sonnenblick EH et al. (1996) Apoptotic and necrotic myocyte cell deaths are independent contributing variables of infarct size in rats. Lab Invest 74: 86-107. PubMed: 8569201.
[43]
Nakagawa T, Shimizu S, Watanabe T, Yamaguchi O, Otsu K et al. (2005) Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death. Nature 434: 652-658. doi:10.1038/nature03317. PubMed: 15800626.
[44]
Hochhauser E, Kivity S, Offen D, Maulik N, Otani H et al. (2003) Bax ablation protects against myocardial ischemia-reperfusion injury in transgenic mice. Am J Physiol Heart Circ Physiol 284: H2351-H2359. PubMed: 12742833.
